IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models
Substance use disorders (SUDs) have an enormous impact on public health. With classic psychedelic-assisted therapies showing initial promise in treating multiple SUDs, it is possible that these treatments will become legally available options for patients with SUDs in the future. This article highli...
Saved in:
Main Authors: | David B. Yaden (Author), Andrea P. Berghella (Author), Peter S. Hendricks (Author), Mary E. Yaden (Author), Michael Levine (Author), Julia S. Rohde (Author), Sandeep Nayak (Author), Matthew W. Johnson (Author), Albert Garcia-Romeu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy
by: Deborah C. Mash
Published: (2023) -
Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression
by: Daniel Meling, et al.
Published: (2024) -
Classic psychedelics, health behavior, and physical health
by: Otto Simonsson, et al.
Published: (2022) -
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
by: Ricarda Evens, et al.
Published: (2023) -
IUPHAR Review: New strategies for medications to treat substance use disorders
by: Ivan D. Montoya, et al.
Published: (2024)